Cargando...
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 mainly causes damage to the lung, as well as other organs and systems such as the hearts, the immune system and so on. Although the pathogen...
Gardado en:
| Publicado en: | Cell Prolif |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7645923/ https://ncbi.nlm.nih.gov/pubmed/33098357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12939 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|